X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
The Washington Legal Foundation has found individual plaintiffs to continue its legal challenge of federal government guidelines that limit advice medical professionals can give to senior citizens about their options under the government’s Medicare Part D prescription drug program. In an amended complaint filed earlier this month in a Washington federal court against top officials at the U.S. Department of Health & Human Services and its Centers for Medicare & Medicare Services, plaintiffs allege the policies violate senior citizens’ first amendment rights. Rebecca Fox v. Michael O. Leavitt, No. 06-01490 (D.C.). The complaint states that the agencies’ policy of “suppressing truthful, non-misleading speech by providers” about the merits of various prescription drug plans “interferes with the ability of Plaintiffs to receive such materials.” Last month, a federal court rejected the legal foundation’s preliminary injunction motion on the grounds that it lacked standing to bring the lawsuit. The U.S. Department of Justice declined to discuss the ongoing lawsuit, but an agency case memo filed in February notes that the marketing guidelines “do not directly regulate providers at all” and that the guideline’s anti-steering provisions are similar to other types of conditions Medicare places on health care providers and suppliers. The memo also noted that the government has an interest in protecting Medicare beneficiaries from providers who might guide a patient into a particular plan for financial gain.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

 
Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.

 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.